|
Home | Technology News Search Engine:
|
|
|
|
Home: Technology News:
|
|
|
(IT-NEWSWIRE.COM, October 02, 2018 ) The cholera vaccines market is estimated to represent a global market of USD 1,367.8 million by 2025 with growth rate of 10.3%. Cholera is a bacterial infection (Vibrio cholerae), primarily caused due to the contaminated food or water intake. Symptoms of it can be mild i.e. watery diarrhea and profuse vomiting, but it can lead to be severe. Normally, patients are treated with oral rehydration solution and in severe condition intake of intravenous fluid is required.
The market is divided into products such as Dukoral, Shanchol, Vaxchora and others. Dukoral, and Shanchol dominated the market. WHO has pre-qualified these two cholera vaccines which will support the market growth. Dukoral was the first oral cholera vaccine to get approval in European Union (EU) during the year 2004.
Request sample copy at: https://www.reportsweb.com/inquiry&RW00011327800/sample
Geographically, North America and Europe recorded highest revenue of the total market. Of which, Europe dominated the market with more than USD 212.8 million revenue in 2017. Developing regions such as Asia Pacific and Latin America are considered to be the fastest growing regional segment owing to the high cholera incidences. For instance, as per the World Health Organization (WHO) statisticscholera spread very rapidly in Latin America which cause nearly 400,000 reported cases and over 4000 reported deaths every year. This fact would in turn boost the demand for cholera vaccines in developing regions, leading to drive the market growth.
Companies such as Merck & Co., GlaxoSmithKline, Sanofi and Pfizer, Inc. are the key players of the market. Collectively these companies accounted for more than 75% revenue share of the global market. Additionally, Novartis AG, Astellas Pharma, Emergent BioSolutions, Takeda Pharmaceuticals, AstraZeneca plc and Mitsubishi Tanabe have also significant presence in this market.
The market size and forecast for each segment has been provided for the period 2014 to 2025, considering 2016 as the base year. The report also provides the compounded annual growth rate (% CAGR) for the forecast period 2017 to 2025 for every reported segment.
The years considered for the study are:
Historical Year - 2014 & 2015
Base Year - 2016
Estimated Year - 2017
Projected Year - 2025
TARGET AUDIENCE
Hospitals
Manufacturers
Traders, Distributors, And Suppliers
Government and Regional Agencies and Research Organizations
Consultants
Distributors
Have any query? Enquire about report at: https://www.reportsweb.com/inquiry&RW00011327800/buying
SCOPE OF THE REPORT
The scope of this report covers the market by its major segments, which include as follows:
Cholera Vaccines Market,By Products
Dukoral
Shanchol
Vaxchora
Others
Cholera Vaccines Market,By Region
North America
Europe
Asia Pacific
Rest of the World
Cholera Vaccines Market,By Country
Further Breakdown of The North America Market
U.S.
Canada
Further Breakdown of The Europe Market
Germany
France
Rest of Europe
Further Breakdown of The APAC Market
India
China
Rest of APAC
Further Breakdown of The Rest of the World Market
Middle East and Africa
Latin America
Get more information at: https://www.reportsweb.com/inquiry&RW00011327800/discount
ReportsWeb.com
Rajat Sahni
+1-646-491-9876
sales@reportsweb.com
Source: EmailWire.Com 
Source: EmailWire.com
|
|
|
|
|
Technology News Headlines
|
|
|
|
|
Technology Business Video Feed
|
|
More Technology Video Feeds
|
|
|
